Latest News for Lithium & Boron Tech Stock (OTC:LBTI)

Lithium & Boron Technology Inc is a Chinese boric acid manufacturing company. The company through its holding manufactures and sells boric acid and related compounds for industrial and consumer use. It offers boric acid manufacturing facilities to produce lithium carbonate for the rapidly growing electric vehicle battery market in China.

News

Intraday Update

Markets

Movers

Trading Ideas

AANNF

AAPL

ABVN

ACIA

ACIW

ACLS

ADBE

ADDDF

ADDYY

ADSK

ADUS

AEBZY

AFGC

AFGVY

AGTC

AHEXY

AILQF

AKRFF

AMADY

AMED

AMRC

ANPDF

ANSS

APAM

APLT

APPF

ARCAY

ARDC

ARES

ARGX

ARVN

ASHTF

ASHTY

ASMIY

ASML

ATGN

ATZAF

AZIHF

BABA

BILI

BIOS

BIRMF

BKNG

BKOR

BLDP

BMCH

BPOP

BRK-A

BRK-B

BTAFF

CABO

CACI

CAMT

CASH

AllianzGI Convertible & Income 2024 Target Term Fund Common Shares of Beneficial Interest

CCOI

CDAY

CDLX

CFFA

CGEN

CHGCY

CHRYY

CIGI

CLGN

CLZNY

CMXHF

CNNE

COHR

COHU

COLL

Stocks That Hit 52-Week Highs On Thursday

ACRE

ACST

AHCHY

ALFVY

ALGT

APTO

ASGN

AUBN

AXAHY

BALMF

BLAGF

BWXT

CATN

CHNG

CIVB

CLPBF

CNXN

CPXWF

CRUS

DEAC

DIOD

DRRX

DSGX

EGIF

ELMA

ENTG

ESKYF

ESPR

FBMS

FTGFF

FUSB

GFGSF

GOLF

GREN

GRMN

GVDNY

HANNF

Hannon Armstrong Sustainable Infrastructure Capital

HASI

HCMLY

HELE

HESAF

ICLR

IDEXY

IFJPY

IIJIY

IMKTA

INFO

INGIY

INTC

IOVA

IRWD

ITCI

JAZZ

JBAXY

KPTI

LAMR

LBTI

Stocks That Hit 52-Week Highs On Monday

LITHIUM & BORON TECH INC by Lithium & Boron Technology, Inc.

Lithium & Boron Technology Inc

Constantino will also continue to support XP in an advisory role for a 12-month period after the transition and will remain a member of XP&#39;s Board of Directors. In addition, current Head of Investor Relations Andr&eacute; Parize, who has been named Chief Investor Relations Officer, effective August 1, 2024, will report to Mr. Mansur.

Management

XP Names Victor Mansur As CFO Effective August 1, 2024, Succeeding Bruno Constantino

HC Wainwright &amp; Co. analyst Douglas Tsao reiterates Praxis Precision Medicine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRAX#NASDAQ">PRAX</a>) with a Buy and maintains $105 price target.

Price Target

Reiteration

Analyst Ratings

PRAX

HC Wainwright & Co. Reiterates Buy on Praxis Precision Medicine, Maintains $105 Price Target

<ul>
<li>First quarter&nbsp;total residential and small and medium business (&quot;SMB&quot;) Internet customers decreased by 72,000. As of&nbsp;March 31, 2024, Charter served a total of 30.5 million residential and SMB Internet customers.</li>
<li>First quarter&nbsp;total residential and SMB mobile lines increased by 486,000. As of&nbsp;March 31, 2024, Charter served a total of 8.3 million mobile lines.</li>
<li>As of&nbsp;March 31, 2024, Charter had a total of 32.0 million residential and SMB customer relationships, excluding mobile-only relationships.</li>
<li>First quarter&nbsp;revenue of&nbsp;$13.7 billion&nbsp;grew by&nbsp;0.2%&nbsp;year-over-year, driven by residential mobile service revenue growth of&nbsp;37.8%&nbsp;and residential Internet revenue growth of&nbsp;1.9%.</li>
</ul>

Earnings

CHTR

Charter Communications Reported Q1 Residential and Small and Medium Business ("SMB") Internet Customers Decrease of 72,000, Residential and SMB Mobile Lines Increase of 486,000

SLCA

U.S. Silica Entered Into A Definitive Agreement To Be Acquired By Funds Managed By Affiliates Of Apollo At An Enterprise Value Of $1.85B

WisdomTree (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WT#NYSE">WT</a>) reported quarterly earnings of $0.12 per share which beat the analyst consensus estimate of $0.11 by 9.09 percent. This is a 71.43 percent increase over earnings of $0.07 per share from the same period last year. The company reported quarterly sales of $96.838 million which beat the analyst consensus estimate of $94.252 million by 2.74 percent. This is a 18.03 percent increase over sales of $82.044 million the same period last year.

Earnings Beats

WisdomTree Q1 2024 Adj EPS $0.12 Beats $0.11 Estimate, Sales $96.838M Beat $94.252M Estimate

Phillips 66 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSX#NYSE">PSX</a>) reported quarterly earnings of $1.90 per share which missed the analyst consensus estimate of $2.17 by 12.44 percent. This is a 54.87 percent decrease over earnings of $4.21 per share from the same period last year. The company reported quarterly sales of $36.436 billion which beat the analyst consensus estimate of $33.075 billion by 10.16 percent. This is a 3.84 percent increase over sales of $35.089 billion the same period last year.

Earnings Misses

Phillips 66 Q1 2024 Adj EPS $1.90 Misses $2.17 Estimate, Sales $36.436B Beat $33.075B Estimate

Virtus Inv (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTS#NASDAQ">VRTS</a>) reported quarterly earnings of $5.41 per share which met the analyst consensus estimate. This is a 28.81 percent increase over earnings of $4.20 per share from the same period last year. The company reported quarterly sales of $222.042 million which beat the analyst consensus estimate of $204.830 million by 8.40 percent. This is a 12.21 percent increase over sales of $197.874 million the same period last year.

VRTS

Virtus Inv Q1 2024 GAAP EPS $5.41, Inline, Sales $222.042M Beat $204.830M Estimate

The European Commission (EC), which has the authority to approve medicines for the European Union (EU), will now review the CHMP recommendation. The final EC decision is expected in June 2024.

Bristol Myers Says EMA's CHMP Recommended Approval Of Opdivo Combination With Cisplatin, Gemcitabine For First-line Treatment Of Adult Patients With Unresectable Or Metastatic Urothelial Carcinoma

Oil States International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OIS#NYSE">OIS</a>) reported quarterly earnings of $0.21 per share which beat the analyst consensus estimate of $(0.01) by 2200 percent. This is a 600 percent increase over earnings of $0.03 per share from the same period last year. The company reported quarterly sales of $167.26 million which missed the analyst consensus estimate of $190.07 million by 12.00 percent. This is a 14.75 percent decrease over sales of $196.20 million the same period last year.

Oil States International Q1 EPS $0.21 Beats $(0.01) Estimate, Sales $167.26M Miss $190.07M Estimate

US Silica Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLCA#NYSE">SLCA</a>) reported quarterly earnings of $0.20 per share which met the analyst consensus estimate. The company reported quarterly sales of $325.900 million which missed the analyst consensus estimate of $336.591 million by 3.18 percent. This is a 26.31 percent decrease over sales of $442.240 million the same period last year.

US Silica Holdings Q1 2024 Adj. EPS $0.20, Inline, Sales $325.900M Miss $336.591M Estimate

Strategic Priorities and Business Update
Phillips 66 is executing its strategic priorities to increase mid-cycle adjusted EBITDA to $14 billion by 2025 and return over 50% of operating cash flow to shareholders. Since July 2022, the company has distributed $9.9 billion through share repurchases and dividends and is on pace to achieve its $13 billion to $15 billion target by year-end 2024.
Phillips 66 plans to monetize assets that no longer fit its long-term strategy. The company is progressing the potential divestiture of its retail marketing business in Germany and Austria. Completion of dispositions is subject to market and other conditions, including customary approvals.

Phillips 66 Says It Is Executing Its Strategic Priorities To Increase Mid-Cycle Adjusted EBITDA To $14B By 2025 And Return Over 50% Of Operating Cash Flow To Shareholders

Increasing 2024&nbsp;guidance
Roper now expects full year 2024 adjusted DEPS of&nbsp;$18.05&nbsp;-&nbsp;$18.25, compared to previous&nbsp;guidance&nbsp;of&nbsp;$17.85&nbsp;-&nbsp;$18.15.
For the&nbsp;second quarter&nbsp;of 2024, the Company expects adjusted DEPS of&nbsp;$4.42&nbsp;-&nbsp;$4.46.

Guidance

Roper Technologies Expects Q2 Adj EPS of $4.42-$4.46 Vs $4.49 Est, FY24 Adj EPS of $18.05-$18.25 (Prior $17.85-$18.15) Vs $18.12 Est

Newell Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWL#NASDAQ">NWL</a>) reported quarterly losses of $(0.00) per share which beat the analyst consensus estimate of $(0.07) by 98.57 percent. This is a 98.33 percent increase over losses of $(0.06) per share from the same period last year. The company reported quarterly sales of $1.653 billion which beat the analyst consensus estimate of $1.644 billion by 0.52 percent. This is a 8.42 percent decrease over sales of $1.805 billion the same period last year.

Newell Brands Q1 2024 Adj EPS $(0.00) Beats $(0.07) Estimate, Sales $1.653B Beat $1.644B Estimate

Sensient Technologies Reiterates FY24 Diluted Earnings Per Share Of $2.80-$2.90 Vs. $2.98 Estimate, Projects Revenue To Grow At Mid-Single-Digit Rate On Local Currency Basis

B of A Securities analyst John Babcock downgrades Hertz Global Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTZ#NASDAQ">HTZ</a>) from Neutral to Underperform and lowers the price target from $9 to $3.

Downgrades

B of A Securities Downgrades Hertz Global Holdings to Underperform, Lowers Price Target to $3

AutoNation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AN#NYSE">AN</a>) reported quarterly earnings of $4.49 per share. This is a 28.62 percent decrease over earnings of $6.29 per share from the same period last year. The company reported $6.49 billion in sales this quarter. This is a 5.88 percent decrease over sales of $6.89 billion the same period last year.

AutoNation Q2 EPS $4.49 Down From $6.29 YoY, Sales $6.49B Down From $6.89B YoY

Wells Fargo analyst Colin Langan upgrades Visteon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VC#NASDAQ">VC</a>) from Underweight to Equal-Weight and raises the price target from $106 to $108.

Upgrades

Wells Fargo Upgrades Visteon to Equal-Weight, Raises Price Target to $108

Charter Communications (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHTR#NASDAQ">CHTR</a>) reported quarterly earnings of $7.55 per share which missed the analyst consensus estimate of $7.84 by 3.7 percent. The company reported quarterly sales of $13.679 billion which missed the analyst consensus estimate of $13.743 billion by 0.47 percent. This is a 0.19 percent increase over sales of $13.653 billion the same period last year.

Charter Communications Q1 2024 GAAP EPS $7.55 Misses $7.84 Estimate, Sales $13.679B Miss $13.743B Estimate

Phillips 66 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSX#NYSE">PSX</a>) reported quarterly earnings of $1.90 per share which missed the analyst consensus estimate of $2.17 by 12.44 percent. This is a 54.87 percent decrease over earnings of $4.21 per share from the same period last year.

Phillips 66 Q1 2024 Adj EPS $1.90 Misses $2.17 Estimate

Needham analyst Laura Martin maintains Alphabet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) with a Buy and raises the price target from $160 to $210.

GOOG

GOOGL

Needham Maintains Buy on Alphabet, Raises Price Target to $210

Lithium & Boron Tech

AAGC

AAGIY

AAWC

ABCE

ABNAF

ABVC

ACAM

Stocks That Hit 52-Week Lows On Tuesday

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Latest News for Lithium & Boron Tech Stock (OTC:LBTI)

Tuesday, March 24, 2020

Thursday, January 09, 2020

Monday, December 23, 2019